Organization: Health Canada
Year: 2022
Month: December
Request Number: A-2022-000840
Request Summary: Adverse Drug Reactions (ADRs) for Rexulti. Report numbers: E2B_05427218, E2B_05428797. ADRs for Sucroferric Oxyhydroxide. Report numbers: E2B_05461870, E2B_05421443. ADRs for PATIROMER. Report numbers: E2B_05406096, E2B_05321703, E2B_05322447, E2B_05339226, E2B_05363908.
Disposition: Disclosed in part
Number of pages: 102